Company Overview of Ardent Pharmaceuticals, Inc.
Ardent Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of delta receptor compounds. It develops a range of drugs for use in moderate to severe pain, urinary incontinence, premature ejaculation, depression, cardioprotection, glaucoma, neuroprotection, immunomodulation, and drug abuse. The company’s DPI-3290 IV formulation is used for acute pain. Ardent Pharmaceuticals, Inc. was formerly known as Delta Pharmaceuticals, Inc. The company is based in Durham, North Carolina. As of 12/20/2004, Ardent Pharmaceuticals, Inc. is a subsidiary of Enhance Biotech, Inc.
631 United Drive
Durham, NC 27713
Key Executives for Ardent Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Seventh Wave Laboratories LLC||United States|
|Huxley Pharmaceuticals, Inc.||United States|
|SNBL U.S.A. Ltd.||United States|
|Personalis, Inc.||United States|
|Bio-One Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- East Township, NY | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Ardent Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.